Concepedia

Max Meyrath

MM

15

Publications

735

Citations

13

H-Index

2014

Active since

Affiliations

Luxembourg Institute of Health(Current)

University of Luxembourg

University of Liège

Heidelberg University

University of Southern Denmark

Max Meyrath is an author at Luxembourg Institute of Health specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2014–2024

15

Publications

15

The atypical chemokine receptor ACKR3/CXCR7 is a broad-spectrum scavenger for opioid peptides

Max Meyrath, Martyna Szpakowska, Julian Zeiner et al. · Nature Communications · 2020 · 139 citations · Full text

A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer

Elin Sjöberg, Max Meyrath, Laura Milde et al. · Clinical Cancer Research · 2019 · 108 citations

Different contributions of chemokine N‐terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3

Martyna Szpakowska, Amanda M. Nevins, Max Meyrath et al. · British Journal of Pharmacology · 2017 · 66 citations · Full text

Assessment of Biased Agonism among Distinct Synthetic Cannabinoid Receptor Agonist Scaffolds

Elise Wouters, Jolien Walraed, Michael J. Robertson et al. · ACS Pharmacology & Translational Science · 2019 · 65 citations · Full text

Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture

Christian Harak, Max Meyrath, Inés Romero‐Brey et al. · Nature Microbiology · 2016 · 57 citations

, , +7

Rows per page

1–5 of 15